| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $323,701,515 | 4 | 100 |
| Mandadi Tilak | EVP, Chief Exp & Tech Officer | 0 | $0 | 1 | $6.23M | $-6.23M |
| ROBBINS LARRY | director | 0 | $0 | 3 | $317.47M | $-317.47M |
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail …
Over the last 12 months, insiders at CVS Health Corp. have bought $0 and sold $323.7M worth of CVS Health Corp. stock.
On average, over the past 5 years, insiders at CVS Health Corp. have bought $971,115 and sold $124.58M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,570 shares for transaction amount of $100,009 was made by SANSONE GUY P (director) on 2025‑06‑05.
| 2026-05-21 | Sale | ROBBINS LARRY | director | 370,462 0.0291% | $93.45 | $34.62M | +2.14% | |
| 2026-05-20 | Sale | ROBBINS LARRY | director | 1.02M 0.0802% | $93.82 | $95.51M | +2.17% | |
| 2026-05-19 | Sale | ROBBINS LARRY | director | 1.98M 0.1559% | $94.45 | $187.34M | +1.16% | |
| 2026-05-08 | Sale | Mandadi Tilak | EVP, Chief Exp & Tech Officer | 69,551 0.0054% | $89.58 | $6.23M | +5.24% | |
| 2025-08-20 | Sale | Finucane Anne A. | director | 7,500 0.0006% | $71.02 | $532,650 | +12.95% | |
| 2025-06-05 | SANSONE GUY P | director | 1,570 0.0001% | $63.70 | $100,009 | +24.50% | ||
| 2025-05-06 | Sale | ROBBINS LARRY | director | 150,000 0.012% | $66.67 | $10M | +17.02% | |
| 2025-05-05 | Sale | ROBBINS LARRY | director | 1.32M 0.1054% | $67.41 | $89.25M | +15.50% | |
| 2025-05-02 | Sale | ROBBINS LARRY | director | 2.28M 0.1814% | $67.86 | $154.44M | +14.63% | |
| 2025-03-05 | Sale | Clark James David | SVP, Cont & Chief Acct Officer | 7,513 0.0006% | $66.35 | $498,488 | +13.34% | |
| 2025-02-18 | Mahoney Michael F | director | 30,000 0.0024% | $66.70 | $2M | +9.43% | ||
| 2025-01-23 | Nelson Steven H | EVP and President, Aetna | 24 <0.0001% | $53.70 | $1,289 | +26.86% | ||
| 2024-10-23 | CAPOZZI HEIDI B | EVP and Chief People Officer | 35 <0.0001% | $56.85 | $1,990 | +16.03% | ||
| 2024-10-02 | CAPOZZI HEIDI B | EVP and Chief People Officer | 10 <0.0001% | $62.24 | $622 | +6.06% | ||
| 2024-09-09 | CAPOZZI HEIDI B | EVP and Chief People Officer | 35 <0.0001% | $56.47 | $1,976 | +15.41% | ||
| 2024-05-02 | LUDWIG EDWARD J | director | 1,000 <0.0001% | $53.88 | $53,879 | +6.99% | ||
| 2024-05-02 | Mahoney Michael F | director | 9,181 0.0007% | $54.49 | $500,294 | +6.99% | ||
| 2024-02-16 | Sale | Shah Prem S | EVP and Pres-Pharm, Consumer W | 29,473 0.0023% | $76.95 | $2.27M | -22.75% | |
| 2023-11-03 | LUDWIG EDWARD J | director | 2,000 0.0002% | $70.47 | $140,930 | -4.45% | ||
| 2023-08-03 | Sale | Clark James David | SVP, Cont & Chief Acct Officer | 25,759.26 0.002% | $74.92 | $1.93M | -5.57% |
| RYAN THOMAS M | Non-Executive Chairman | 764683 0.0598% | $69.9M | 2 | 20 | +6.98% |
| Moriarty Thomas M | EVP & General Counsel | 608129 0.0475% | $55.59M | 1 | 9 | +14.88% |
| Lynch Karen S | President and CEO | 431392 0.0337% | $39.43M | 1 | 1 | +2.38% |
| HEADRICK ROGER L | director | 324262 0.0254% | $29.64M | 1 | 0 | +3.13% |
| Brennan Troyen A | EVP and Chief Medical Officer | 138246 0.0108% | $12.64M | 1 | 25 | |
| DORMAN DAVID W | director | 122302 0.0096% | $11.18M | 2 | 0 | +12.47% |
| BROWN C DAVID II | director | 111252 0.0087% | $10.17M | 2 | 4 | +11.67% |
| Lotvin Alan | EVP&President-PharmacyServices | 109183 0.0085% | $9.98M | 1 | 5 | +6.05% |
| MURRAY TERRENCE | director | 80506 0.0063% | $7.36M | 4 | 3 | +6.22% |
| WILLIAMS KRISTEN GIBNEY | director | 64679 0.0051% | $5.91M | 1 | 3 | +7.58% |
| Mahoney Michael F | director | 39356 0.0031% | $3.6M | 2 | 0 | +8.21% |
| Lofberg Per GH | EVP | 23419 0.0018% | $2.14M | 5 | 3 | +6.93% |
| LUDWIG EDWARD J | director | 21630 0.0017% | $1.98M | 7 | 0 | +8.71% |
| GOLD STEPHEN J | EVP & CIO | 21560 0.0017% | $1.97M | 1 | 2 | +6.79% |
| FERDINANDI V MICHAEL | Senior Vice President | 16021 0.0013% | $1.46M | 1 | 5 | +36.06% |
| AGUIRRE FERNANDO | director | 16222 0.0013% | $1.48M | 2 | 0 | +11.6% |
| SANSONE GUY P | director | 12007 0.0009% | $1.1M | 1 | 0 | +24.5% |
| MCGUIGAN STUART M | SVP and CIO | 10967 0.0009% | $1M | 1 | 3 | +14.83% |
| SWIFT RICHARD J | director | 3258 0.0003% | $297,813.78 | 1 | 1 | +34.74% |
| BODINE CHRIS W | Executive Vice President | 2583 0.0002% | $236,121.04 | 1 | 7 | +1.81% |
| Nelson Steven H | EVP and President, Aetna | 24 0% | $2,193.84 | 1 | 0 | +26.86% |
| Denton David M | EVP and CFO | 403 0% | $36,836.10 | 1 | 8 | |
| CAPOZZI HEIDI B | EVP and Chief People Officer | 85 0% | $7,769.85 | 3 | 0 | +12.5% |
| Increased Positions | 964 | +47.51% | 76M | +6.81% |
| Decreased Positions | 887 | -43.72% | 63M | -5.59% |
| New Positions | 251 | New | 14M | New |
| Sold Out Positions | 127 | Sold Out | 4M | Sold Out |
| Total Postitions | 2,106 | +3.79% | 1B | +1.22% |
| Blackrock, Inc. | $9.6M | 9.44% | 119.84M | -3M | -2.32% | 2025-09-30 |
| Vanguard Group Inc | $9.53M | 9.37% | 118.89M | -2M | -1.26% | 2025-09-30 |
| Dodge & Cox | $5.86M | 5.77% | 73.18M | -112,180 | -0.15% | 2025-09-30 |
| Capital World Investors | $5.48M | 5.39% | 68.38M | +1M | +2.12% | 2025-09-30 |
| State Street Corp | $4.72M | 4.64% | 58.94M | +149,701 | +0.26% | 2025-09-30 |
| Fmr Llc | $3.47M | 3.42% | 43.34M | -2M | -4.99% | 2025-09-30 |
| Jpmorgan Chase & Co | $2.83M | 2.78% | 35.28M | +8M | +31.25% | 2025-09-30 |
| Geode Capital Management, Llc | $2.32M | 2.28% | 28.99M | +352,532 | +1.23% | 2025-09-30 |
| Capital International Investors | $2.14M | 2.1% | 26.69M | +302,499 | +1.15% | 2025-09-30 |
| Invesco Ltd. | $1.95M | 1.91% | 24.29M | +760,579 | +3.23% | 2025-09-30 |